ETFMG Treatments Testing and Advancements ETF - USD Stock

GERM

US26924G7631

Main features

	US26924G7631	Fees	0%	Dividend Policy	Distribution
Currency	USD	AuM (SAR)	-	Replication Method	Direct (Physical)
Number of securities	51	AuM evolution	-	Date of creation	17/06/2020

Top Holdings

6c17fc68d8d775.zUrzHiKzwAfRgskPVWcgJnBpuRdyVn6bS7moqezWrz4.jCuRcW6FkTa52uRpETNmED023203PR_8D9qbxo20-GeJCLlcR9-hMunD_Q

Name	Indicative Price	Change	Weight
MODERNA, INC.	248.69USD	-0.85%	6.69%
ALNYLAM PHARMACEUTICALS, INC.	159.85USD	+5.41%	6.12%
LABCORP HOLDINGS INC.	372.23USD	+0.36%	5.51%
QUEST DIAGNOSTICS INCORPORATED	258.69USD	+0.10%	5.28%
IMMUNITYBIO, INC.	6.670USD	-1.11%	4.97%
VAXCYTE, INC.	68.62USD	+3.41%	4.29%
QUIDELORTHO CORPORATION	11.91USD	+3.39%	3.83%
BIO-RAD LABORATORIES, INC.	386.00USD	-0.12%	3.73%
DYNAVAX TECHNOLOGIES CORPORATION	15.50USD	-.--%	3.6%
ZAI LAB LIMITED	26.42USD	-0.04%	3.51%

View the 50 instruments that make up the ETF

Easily sort and filter through all available ETFs

Access the ETF Screener

Economic news

	And now, 50 basis points for the Fed?	11-11
	Swiss Re's 9m net income up 3%	11-09
	Swiss Re's 9-month net income up 3%	11-09
	Paraguayan Digital Bank Ueno Collapses amid Corruption Scandal	11-09
	What if the S&P 500 rebounded to 8100 by the end of the year?	11-09
	Bubble or no bubble?	11-07
	Global food prices (FAO) in October: cereals and meat decline, sugar surges	11-06
	The bond market welcomes the Democrats' victory	11-06
	Data Centers After the Midterms: Is the AI Trade Really at Risk?	11-06
	Solid US employment figures make the case for tighter monetary policy	11-06

More news

In partnership with

Investment objective

Asset Classes	Stocks
Geographical Focus	United States
Theme and Sector	Tomorrow's Treatments

The Funds investment objective seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the Prime Treatments, Testing and Advancements Index.